This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1502-47-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
>97%
0
Out of Stock
Shanghai
Inquiry
1502-47-2 / 11-imino-2,4,6,8,10,12,13-heptazatricyclo[7.3.1.05,13]trideca-1(12),2,4,7,9-pentaene-3,7-diamine
Standard CAS: 1502-47-2
Multi CAS: No
Basic Information
copy
CAS
1502-47-2 copy
Multi CAS
No copy
Molecular Formula
C6H6N10 copy
Molecular Weight
218.180000 copy
Exact Mass
218.077690 copy
SMILES
C1(=NC2=NC(=N)N=C3N2C(=NC(=N3)N)N1)N copy
InChI
InChI=1S/C6H6N10/c7-1-10-4-12-2(8)14-6-15-3(9)13-5(11-1)16(4)6/h(H6,7,8,9,10,11,12,13,14,15) copy
InChIKey
YSRVJVDFHZYRPA-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
16 copy
Aromatic heavy atom count
10 copy
H-bond acceptors
10 copy
H-bond donors
4 copy
Molar refractivity
53.75 copy
TPSA
156.25 copy
LogP / Solubility
WLOGP
-2.05 copy
MLOGP
-1.8 copy
XLogP3
-2 copy
Consensus LogP
-1.95 copy
Log S (ESOL)
-0.37 copy
Class (ESOL)
Very soluble copy
Log S (Ali)
0.13 copy
Class (Ali)
Highly soluble copy
Log S (SILICOS-IT)
0.62 copy
Class (SILICOS-IT)
Highly soluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-5.5 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
No copy
Egan
No copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy
Safety & Transport
copy
GHS Hazard Statements
Not Classified
Reported as not meeting GHS hazard criteria by 38 of 38 companies. For more detailed information, please visit ECHA C&L website. copy